Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer

Chimeric antigen receptor (CAR) T-cell therapy can lead to dramatic clinical responses in B-cell malignancies. However, early clinical trials with CAR T-cell therapy in non–B-cell malignancies have been disappointing to date, suggesting that tumor-intrinsic features contribute to resistance. To inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagel, Kimberly R., Arafeh, Rand, Gang, Sydney, Arnoff, Taylor E., Larson, Rebecca C., Doench, John G., Mathewson, Nathan D., Wucherpfennig, Kai W., Maus, Marcela V., Hahn, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Tumor Biology and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929516/
https://www.ncbi.nlm.nih.gov/pubmed/36548402
http://dx.doi.org/10.1158/0008-5472.CAN-22-2245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929516/
https://www.ncbi.nlm.nih.gov/pubmed/36548402
http://dx.doi.org/10.1158/0008-5472.CAN-22-2245

Ejemplares similares